Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VBI Vaccines
Biotech
Brii pays VBI $15M for global rights to hepB program and more
Brii is handing VBI $15 million for a global license to a hepatitis B program—and an ongoing look at its partner’s financial situation.
Nick Paul Taylor
Jul 6, 2023 6:00am
VBI Vaccines pares down pipeline, staff to focus on hepatitis B
Apr 4, 2023 10:56am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am